Active B12 Test Market: Global Industry Analysis and Forecast (2024-2030)

  • Active B12 Test Market size was valued at USD 182.23 Mn. in 2023 and the Active B12 Test revenue is expected to grow at a CAGR of 24.7% from 2024 to 2030, reaching nearly USD 854.45 Mn. by 2030.

  • Format : PDF | Report ID : SMR_2051

Active B12 Test Market Overview:

Vitamin B12 deficiency is a serious health issue among the elderly population. It is no longer a rare kind of disease; it prevails as a common condition in the elderly population. Vegetarians mainly suffer from vitamin B12 deficiency for the reason that natural source of vitamin B12 mainly comprises of food from the animal origin. A B12 test is a blood test used to determine the B12 levels in your body. Vitamin B12 helps to produce red blood cells, which prevents anaemia, which causes weakness and exhaustion. It also plays a role in neurological function by governing the amounts of chemicals called neurotransmitters, which move nerve impulses from one cell to another.

 

The global active B12 testing market is growing gradually because of rising consumer awareness of pernicious anaemia, adult macrocytic Lancia, and folate deficiency. The main driver impacting the active B12 global market is the growth of vitamin deficiencies among patients because of changed lifestyle choices, such as smoking, poor eating, and lack of exercise. Further, the global market is expected to benefit from increased patient awareness regarding the disparity in the health problems of patients and the potential observed benefits of active B12.

Active B12 Test Market

 

To get more Insights: Request Free Sample Report

 

Active B12 Test Market Dynamics:

Rising B12 Deficiency in the Population is Driving the Growth of Active B12 Test Market.

Increasing incidence of vitamin B12 deficient disorders is driving the market growth of active B12 testing. Active B12 Test, has been closely watched by end-users like doctors, hospitals, and diagnostic labs because of increasing numbers of adult cases of macrocytic Lancia-related conditions like folic acid deficiency or vitamin B12 deficiencies in many parts of the world. In addition, the rise of macrocytic Lancia among expecting mothers resulting from a deficiency of dietary intake during pregnancy provide a fulfilling demand in terms of both volume and value. The growing awareness among consumers about adult macrocytic Lancia, pernicious anaemia, and folate insufficiency is leading to an increase in the global market for active B12 testing, driving the Active B12 Test Market growth.

 

Technical and Regulatory Factors Affect the Growth of the Active B12 Test Market.

One of the biggest issues for Active B12 Testing industry is ensuring that the Active B12 tests provide accurate and consistent results. Standardization is crucial because differences in test kits and methods lead to inconsistent results. A more complex procedure with advanced equipment and knowledge is required for the active B12 test compared with the total B12 test, and these limit its general application. Justification for widespread use becomes relevant because new diagnostic test certification processes are costly to develop. Further, the process entails much time and is made more complicated by different requirements in different locations. Continuous adherence to the requirements and standards of regulation is also important.

 

This includes post-market surveillance, manufacturing processes, and quality control. Active B12 testing also reflect in clinical guidelines before it is allowed to be used in clinical practice. Adoption process is also slow where there is weak support from medical societies. All these factors are affecting the growth of the Active B12 Test Market.

 

Active B12 Test Market Segment Analysis:

By Test Type, ELISA test held the largest Active B12 Test Market share in 2023. It is to be expected, since ELISA tests are recommended by all guidelines for performing B12 testing because ELISA assays, because of their excellent sensitivity, specificity, and ease of use, are so effective and reliable for the detection of active B12 levels critical in both vitamin B12 deficiency diagnosis and therapy that they are used very widely in clinical labs. ELISA is well known and trusted test in the world, which is recommended by so many physicians around the world. All these factors are driving the growth of the segment in the market.

Active B12 Test Market1

Active B12 Test Market Regional Insight:

North America accounts for the largest share in the active B12 test market in 2023, ensuring that it retains the leading regional position. This is primarily attributed to the highly developed healthcare system, which is among the regions important attributes alongside high awareness of vitamin deficiency and the well-established diagnostics industry. Increasing morbidity because of vitamin B12 deficiency as a result of changing dietary practices and a rise in the number of people affected by chronic diseases also remains a key driver for the active B12 test market in North America. Availability and adoption of modern diagnostic tests in the region are further inspired by the presence of key market players and continuous research and development that has always led the region to take the first position in the Active B12 Test Market. All these factors are propelling the growth of the market in the region.

Active B12 Test Market2

Active B12 Test Market Competitive Landscape:

  • In March 2024, Axis-Shield Diagnostics announced the acquisition of a leading biotech firm specializing in vitamin deficiency diagnostics. This strategic move aims to expand Axis-Shield’s portfolio of diagnostic tests, particularly in the Active B12 Test Market.
  • In April 2024, Abbott launched an innovative Active B12 Test kit designed for enhanced accuracy and ease of use in clinical settings. This new product features advanced assay technology that provides faster and more reliable results, catering to the increasing demand for precise vitamin B12 diagnostics.

Active B12 Test Market

Market Size in 2023

USD 182.23 Mn.

Market Size in 2030

USD 854.45 Mn.

CAGR (2024-2030)

24.7 %

Historic Data

2018-2022

Base Year

2023

Forecast Period

2024-2030

   Segments

By Test Type

ELISA Assay

Enzyme Immunoassay

Others

By Application

Folate Deficiency Anaemia

Pernicious Anaemia

Macrocytic Anaemia

Others

Regional Scope

North America- United States, Canada, and Mexico

Europe – UK, France, Germany, Italy, Spain, Sweden, Russia, and Rest of Europe

Asia Pacific – China, India, Japan, South Korea, Australia, ASEAN, Rest of APAC

Middle East and Africa - South Africa, GCC, Egypt, Rest of the Middle East and Africa

South America – Brazil, Argentina, Rest of South America

 

Active B12 Test Market Key Players:

  1. Abbott
  2. Siemens Healthcare Private Limited
  3. DiaSorin
  4. Roche
  5. LifeSpan BioSciences
  6. Demeditec Diagnostics
  7. altona Diagnostics
  8. Pathkind Diagnostics Pvt. Ltd
  9. Beckman Coulter, Inc.
  10. Randox Laboratories Ltd.
  11. Metropolis Healthcare Limited
  12. Sussex Pathology Limited
  13. Australian Clinical Labs
  14. Blue Horizon Blood Tests
  15. Testing.com
  16. Lupin Diagnostics
  17. Humankind Ventures Ltd.
  18. LalPathLabs.com
  19. Apollo 24|7
  20. Medichecks
  21. XX Inc.


Frequently Asked Questions

Rising B12 deficiency in the population is the driver of the Active B12 Test Market.

1.    Active B12 Test Market: Research Methodology 
2.    Active B12 Test Market: Executive Summary
3.    Active B12 Test Market: Competitive Landscape
4.    Potential Areas for Investment

4.1. Stellar Competition Matrix
4.2. Competitive Landscape
4.3. Key Players Benchmarking
4.4. Market Structure
4.4.1.    Market Leaders 
4.4.2.    Market Followers
4.4.3.    Emerging Players

4.5. Consolidation of the Market
5.    Active B12 Test Market Import Export Landscape
5.1. Import Trends
5.2. Export Trends
5.3. Regulatory Compliance
5.4. Major Export Destinations
5.5. Import-Export Disparities
6.    Active B12 Test Market: Dynamics
6.1. Market Trends by Region
6.1.1.    North America
6.1.2.    Europe
6.1.3.    Asia Pacific
6.1.4.    Middle East and Africa
6.1.5.    South America

6.2. Market Drivers by Region
6.2.1.    North America
6.2.2.    Europe
6.2.3.    Asia Pacific
6.2.4.    Middle East and Africa
6.2.5.    South America

6.3. Market Restraints
6.4. Market Opportunities
6.5. Market Challenges
6.6. PORTER’s Five Forces Analysis
6.7. PESTLE Analysis
6.8. Strategies for New Entrants to Penetrate the Market
6.9. Regulatory Landscape by Region
6.9.1.    North America
6.9.2.    Europe
6.9.3.    Asia Pacific
6.9.4.    Middle East and Africa
6.9.5.    South America

7.    Active B12 Test Market Size and Forecast by Segments (by Value Units)
7.1. Active B12 Test Market Size and Forecast, by Test Type (2023-2030)
7.1.1.    ELISA Assay
7.1.2.    Enzyme Immunoassay
7.1.3.    Others

7.2. Active B12 Test Market Size and Forecast, by Application (2023-2030)
7.2.1.    Folate Deficiency Anaemia
7.2.2.    Pernicious Anaemia
7.2.3.    Macrocytic Anaemia
7.2.4.    Others

7.3. Active B12 Test Market Size and Forecast, by Region (2023-2030)
7.3.1.    North America
7.3.2.    Europe
7.3.3.    Asia Pacific
7.3.4.    Middle East and Africa
7.3.5.    South America

8.    North America Active B12 Test Market Size and Forecast (by Value Units)
8.1. North America Active B12 Test Market Size and Forecast, by Test Type (2023-2030)
8.1.1.    ELISA Assay
8.1.2.    Enzyme Immunoassay
8.1.3.    Others

8.2. Active B12 Test Market Size and Forecast, by Application (2023-2030)
8.2.1.    Folate Deficiency Anaemia
8.2.2.    Pernicious Anaemia
8.2.3.    Macrocytic Anaemia
8.2.4.    Others

8.3. North America Active B12 Test Market Size and Forecast, by Country (2023-2030)
8.3.1.    United States
8.3.2.    Canada
8.3.3.    Mexico

9.    Europe Active B12 Test Market Size and Forecast (by Value Units)
9.1. Europe Active B12 Test Market Size and Forecast, by Test Type (2023-2030)
9.1.1.    ELISA Assay
9.1.2.    Enzyme Immunoassay
9.1.3.    Others

9.2. Active B12 Test Market Size and Forecast, by Application (2023-2030)
9.2.1.    Folate Deficiency Anaemia
9.2.2.    Pernicious Anaemia
9.2.3.    Macrocytic Anaemia
9.2.4.    Others

9.3. Europe Active B12 Test Market Size and Forecast, by Country (2023-2030)
9.3.1.    UK
9.3.2.    France
9.3.3.    Germany
9.3.4.    Italy
9.3.5.    Spain
9.3.6.    Sweden
9.3.7.    Russia 
9.3.8.    Rest of Europe

10.    Asia Pacific Active B12 Test Market Size and Forecast (by Value Units)
10.1. Asia Pacific Active B12 Test Market Size and Forecast, by Test Type (2023-2030)
10.1.1.    ELISA Assay
10.1.2.    Enzyme Immunoassay
10.1.3.    Others

10.2. Active B12 Test Market Size and Forecast, by Application (2023-2030)
10.2.1.    Folate Deficiency Anaemia
10.2.2.    Pernicious Anaemia
10.2.3.    Macrocytic Anaemia
10.2.4.    Others

10.3. Asia Pacific Air Traffic Control (ATC) Communications Market Size and Forecast, by Country (2023-2030)
10.3.1.    China
10.3.2.    S Korea
10.3.3.    Japan
10.3.4.    India
10.3.5.    Australia
10.3.6.    Indonesia 
10.3.7.    Malaysia
10.3.8.    Vietnam
10.3.9.    Taiwan
10.3.10.    Bangladesh
10.3.11.    Pakistan
10.3.12.    Rest of Asia Pacific

11.    Middle East and Africa Active B12 Test Market Size and Forecast (by Value Units)
11.1. Middle East and Africa Active B12 Test Market Size and Forecast, by Test Type (2023-2030)
11.1.1.    ELISA Assay
11.1.2.    Enzyme Immunoassay
11.1.3.    Others

11.2. Active B12 Test Market Size and Forecast, by Application (2023-2030)
11.2.1.    Folate Deficiency Anaemia
11.2.2.    Pernicious Anaemia
11.2.3.    Macrocytic Anaemia
11.2.4.    Others

11.3. Middle East and Africa Active B12 Test Market Size and Forecast, by Country (2023-2030)
11.3.1.    South Africa
11.3.2.    GCC
11.3.3.    Egypt
11.3.4.    Nigeria
11.3.5.    Rest of ME&A

12.    South America Active B12 Test Market Size and Forecast (by Value Units)
12.1. South America Active B12 Test Market Size and Forecast, by Test Type (2023-2030)
12.1.1.    ELISA Assay
12.1.2.    Enzyme Immunoassay
12.1.3.    Others

12.2. Active B12 Test Market Size and Forecast, by Application (2023-2030)
12.2.1.    Folate Deficiency Anaemia
12.2.2.    Pernicious Anaemia
12.2.3.    Macrocytic Anaemia
12.2.4.    Others

12.3. South America Active B12 Test Market Size and Forecast, by Country (2023-2030)
12.3.1.    Brazil
12.3.2.    Argentina
12.3.3.    Rest of South America

13.    Company Profile: Key players
13.1. Abbott
13.1.1.1.    Company Overview
13.1.1.2.    Financial Overview
13.1.1.3.    Business Portfolio
13.1.1.4.    SWOT Analysis
13.1.1.5.    Business Strategy 
13.1.1.6.    Recent Developments

13.2. Siemens Healthcare Private Limited 
13.3. DiaSorin
13.4. Roche
13.5. LifeSpan BioSciences
13.6. Demeditec Diagnostics
13.7. altona Diagnostics
13.8. Pathkind Diagnostics Pvt. Ltd
13.9. Beckman Coulter, Inc.
13.10. Randox Laboratories Ltd.
13.11. Metropolis Healthcare Limited
13.12. Sussex Pathology Limited
13.13. Australian Clinical Labs
13.14. Blue Horizon Blood Tests
13.15. Testing.com
13.16. Lupin Diagnostics
13.17. Humankind Ventures Ltd.
13.18. LalPathLabs.com
13.19. Apollo 24|7
13.20. Medichecks
13.21. XX Inc.
14.    Key Findings
15.    Industry Recommendation

Enquiry Before Buy


Request Sample PDF